'Virtual' drug research is becoming a permanent reality as the coronavirus upends clinical trials and fuels a new breed of startups

· The novel coronavirus has upended many parts of the US healthcare system.
· One of them is the way drugmakers test new medicines to figure out if they work, called clinical trials.
· To curb delays, giant pharmas are doing more research away from hospitals and clinics.
· Called virtual trials, the approach relies on...